Profile
GMVD ISRG BDX BDXA ALC RMD
Company Name G Medical Innovations Holdings Ltd Intuitive Surgical, Inc. Becton, Dickinson and Company Becton, Dickinson and Company Alcon Inc. ResMed Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies
Market Cap $1.80M $173.36B $59.94B $55.91B $39.26B $37.85B
Employees 0.08K 15.64K 70.00K 0.00K 25.60K 9.98K
CEO Yacov Geva David J. Rosa Thomas E. Polen Jr. - David J. Endicott Michael J. Farrell
Ratings
GMVD ISRG BDX BDXA ALC RMD
Quant Rating Score 1 3 5 3 4
Quant Rating Strong Sell Neutral Strong Buy Neutral Buy
Trading
GMVD ISRG BDX BDXA ALC RMD
Last Close $0.1835 $546.71 $190.98 $59.24 $76.61 $244.71
High 52 $0.18 $610.45 $249.08 $59.24 $98.3 $293.73
Low 52 $0.18 $429.59 $165.15 $59.24 $72.05 $204.58
Price vs. 52 Week High 1.94 % -10.44 % -23.33 % 0 % -22.07 % -16.69 %
Price vs. 52 Week Low 1.94 % 27.26 % 15.64 % 0 % 6.33 % 19.62 %
Total Return
GMVD ISRG BDX BDXA ALC RMD
1 Month Return 0 % 22.54 % 0.99 % 0 % 2 % -8.72 %
3 Month Return 0 % 13.64 % -2.06 % 0 % -13.07 % -14.47 %
6 Month Return 0 % -3 % 8.88 % 0 % -14.72 % -2.77 %
9 Month Return 0 % -9.02 % -15.17 % 0 % -14.35 % 6.13 %
YTD Return 0 % 4.74 % -15.82 % 0 % -9.75 % 7.01 %
1 Year Return 0 % 1.46 % -14.22 % 0 % -10.32 % 2.77 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
GMVD ISRG BDX BDXA ALC RMD
Dividend Yield Percentage (TTM) - - 1.99 % 2.18 % 0.42 % 0.87 %
Dividend Paid and Capex Coverage Ration (TTM) -8.71 % 4.3 % 1.75 % 1.74 % 3.02 % 4.31 %
Dividend Per Share (TTM) - - 4.17 % 3.95 % 0.33 % 2.26 %
Payout Ratio (TTM) - - 71.28 % 67.9 % 15.49 % 22.31 %
Growth
GMVD ISRG BDX BDXA ALC RMD
Asset Growth -54.12 % - 18.95 %
Gross Profit Growth -47.8 % 18.13 % 15.05 %
Revenue Growth -12.61 % 20.51 % 9.84 %
Revenue 3 Year -100 % 61.21 % 43.19 %
Revenue 5 Year -100 % 127.11 % 71.22 %
Revenue 10 Year - 294.9 % 193.47 %
EBIT Growth -159.71 % 40.98 % 28.01 %
Net Income Growth 6.25 % 22.97 % 37.2 %
Net Income 3 Yeari Growth Per Share 100 % 115.26 % 78.91 %
Net Income 5 Yeari Growth Per Share 100 % 164.83 % 121.66 %
Net Income 10 Yeari Growth Per Share - 353.8 % 280.03 %
Operating Income Growth -173.09 % 25.4 % 27.69 %
Operating Cash Flow Growth (CFG) -60.77 % - 25 %
Operating 3 Year CFG - -100 % 396.61 %
Operating 5 Year CFG - -100 % 114.79 %
Operating 10 Year CFG - -100 % 337.65 %
EPS Growth 100 % 22.32 % 37.61 %
EPS Diluted Growth 100 % 22.59 % 37.43 %
Book Value Per Share 100 % -100 % 22.95 %
Share Holder 3 Year Equity Growth Per Share 100 % -100 % 76.79 %
Share Holder 5 Year Equity Growth Per Share -100 % -100 % 135.12 %
Share Holder 10 Year Equity Growth Per Share - -100 % 259.96 %
Dividend Per Share Growth - - 10.35 %
Dividend 3 Year Growth Per Share - - 26.15 %
Dividend 5 Year Growth Per Share - - 35.87 %
Dividend 10 Year Growth Per Share - - 89.26 %
Debt Growth -73.32 % - -2.53 %
Free Cash Flow Growth -71.04 % - 29.18 %
Updated On 31 Dec 2022 31 Dec 2025 30 Jun 2025
Profitability
GMVD ISRG BDX BDXA ALC RMD
Gross Profit Margin TTM 17.74 % 66.06 % 45.44 % 45.76 % 55.12 % 60.08 %
Return on Assets TTM -289.28 % 14.76 % 3.03 % 3.2 % 3.32 % 17.31 %
Return on Equity TTM 208.58 % 16.72 % 6.63 % 6.38 % 4.77 % 25.13 %
Return on Capital Employed TTM 639.23 % 16.78 % 5.48 % 5.06 % 5.06 % 24.74 %
Net Income Per EBT TTM 100.11 % 86.25 % 89.16 % 85.17 % 84.1 % 82.6 %
EBT Per Ebit TTM 50.86 % 112.42 % 73 % 75.87 % 86.34 % 99.79 %
EBIT Per Revenue TTM -620.14 % 29.27 % 11.8 % 12.4 % 14.16 % 33.18 %
Cash Flow To Debt Ratio TTM -883.32 % - 17.88 % 18.87 % 39.18 % 222.53 %
Receivables Turnover TTM 4.68 7.27 7.29 8.74 5.26 5.49
Payables Turnover TTM 0.78 11.73 - - 5.11 7.87
Inventory Turnover TTM 12.45 1.92 3.06 2.91 1.88 2.22
Fixed Asset Turnover TTM 166.98 % 195.4 % 312.12 % 314.44 % 198.09 % 724.52 %
Asset Turnover TTM 91.61 % 52.01 % 39.47 % 39.98 % 32.34 % 63.28 %
Operating Cash Flow Per Share TTM - 8.34 11.97 11.91 4.16 12.86
Free Cash Flow Per Share TTM - 6.4 9.32 9.23 3.11 12.06
Cash Per Share TTM - 1383.15 % 299.71 % 263.44 % 303.41 % 944.79 %
Operating Cash Flow Sales Ratio TTM -418.08 % 29.42 % 15.71 % 15.48 % 20.13 % 35.82 %
Free Cash Flow Operating Cash Flow Ratio TTM 111.48 % 76.72 % 77.84 % 77.52 % 74.75 % 93.83 %
Cash Flow Coverage Ratios TTM -883.32 % - 17.88 % 18.87 % 39.18 % 222.53 %
Price To Free Cash Flows Ratio TTM -0.09 76.32 22.45 19.55 25.61 21.42
Price To Operating Cash Flows Ratio TTM - 58.52 17.55 15.17 19.09 20.16
Price Cash Flow Ratio TTM - 58.52 17.55 15.17 19.09 20.16
Income Statement (TTM)
GMVD ISRG BDX BDXA ALC RMD
Revenue $0B $10.06B $21.84B $21.84B $9.91B $5.15B
Gross Profit $0B $6.64B $9.92B $9.92B $5.51B $3.05B
Gross Profit Ratio 17.74% 66% 45.44% 45.44% 55.61% 59.36%
EBITDA $-0.04B $3.62B $4.96B $4.96B $2.68B $1.91B
Net Income $-0.01B $2.86B $1.68B $1.68B $1.02B $1.4B
EPS Diluted - 7.87 5.83 5.83 2.05 9.51
Balance Sheet (MRQ)
GMVD ISRG BDX BDXA ALC RMD
Long Term Debt $0B $0.26B $17.62B $17.62B $4.97B $0.81B
Total Liabilities $0.01B $2.69B $29.94B $29.94B $8.79B $2.21B
Total Equity $-0B $17.94B $25.39B $25.39B $21.55B $5.97B
Total Investments $0B $5.87B $0.01B $0.01B $0.91B $0.09B
Total Debt $0B $0.3B $19.18B $19.18B $5.14B $0.85B
Total Assets $0B $20.63B $55.33B $55.33B $30.35B $8.17B
Cash Flow Statement (TTM)
GMVD ISRG BDX BDXA ALC RMD
Net Income $-0.03B $2.88B $1.68B $1.68B $1.02B $1.4B
Inventory $-0B $-1.06B $-0.41B $-0.41B $-0.05B $-0.08B
Dividends Paid $0B $0B $-1.2B $-1.2B $-0.13B $-0.31B
Operating Cash Flow $-0.02B $3.03B $3.43B $3.43B $2.08B $1.75B
Capital Expenditure $-0B $-0.54B $-0.76B $-0.76B $-0.67B $-0.09B
Related Stocks
Ticker Name Price
AKYA Akoya Biosciences, Inc. 1.29
ALC Alcon Inc. 78.59
ANGO AngioDynamics, Inc. 10.99
APR Apria, Inc. 37.5
ATR AptarGroup, Inc. 140.62
ATRC AtriCure, Inc. 31.94
ATRI Atrion Corporation 459.92
ATRS Antares Pharma, Inc. 5.59
AVGR Avinger, Inc. 0.474
AVTR Avantor, Inc. 9.195
AZTA Azenta, Inc. 28.21
BAX Baxter International Inc. 19.435
BDX Becton, Dickinson and Company 178.115
BDXA Becton, Dickinson and Company 59.24
BDXB Becton, Dickinson and Company 48.16
BLCO Bausch + Lomb Corporation 16.7
BLFS BioLife Solutions, Inc. 21.61
COO The Cooper Companies, Inc. 81.65
DXR Daxor Corporation 12.58
EKSO Ekso Bionics Holdings, Inc. 9.2
Unlock